During the past trading week (July 22 to 26), a maligned Canadian cannabis firm removed executives from leadership positions at the company.

A plan from Quebec to ban most edible cannabis products made headlines, and the launch of a new cannabis exchange-traded fund (ETF) also caught attention.

Here’s a closer look at some of the biggest news during last week’s trading period.

CannTrust sacks CEO

Shares of CannTrust Holdings (NYSE:CTST,TSX:TRST) received a brief boost following the dismissal of the company’s leadership team. The firm has been embroiled in a scandal since Health Canada found illegitimate growing at CannTrust’s facility in Pelham, Ontario.

New reports indicate that several executives at the company, including CEO Peter Aceto, were aware of the improper growing operations and encouraged a continued cover up. Additionally, the company shot a promotional video in which the unlicensed rooms can be seen.

After the new revelations in the CannTrust scandal, an internal investigation of the company came to the conclusion that a management change was needed.

On Thursday (July 25), the firm informed market watchers that Aceto had been terminated effective immediately. The board of directors also requested the resignation of Eric Paul, former CEO, co-founder and chair of the company.

Robert Marcovitch, who was appointed by CannTrust’s board to lead an investigation into the non-compliance issues, has been appointed interim CEO. Marcovitch previously acted as CEO of winter sports equipment company K2 Sports.

Shares of CannTrust in New York immediately jumped 12.82 percent during after-hours trading on Thursday. Once Friday’s trading session started, shares of the firm opened at US$2.20. As of 11:26 a.m. EDT, CannTrust’s NYSE shares were up 15.38 percent.

Similarly, in Toronto the company was trading up 13.95 percent at C$2.94 at 11:31 a.m. EDT on Friday.

British tobacco company gets cannabis exposure

Imperial Brands (LSE:IMB,OTCQX:IMBBF) announced a C$123 million investment into Auxly Cannabis Group (TSXV:XLY,OTCQX:CBWTF) for a 19.9 percent stake in the Canadian company.

“The shared ability to rapidly innovate as the Canadian market evolves is key to future growth and Auxly will work closely with a small dedicated team from Nerudia in developing a portfolio of new and enhanced brands and products,” Imperial said in a statement.

As part of the agreement, Auxly will become the exclusive cannabis partner for Imperial on a global scale. Auxly will also get access to the licenses for vaporizer technology from Imperial’s subsidiary Nerudia.

Quebec moves forward with ban on cannabis edibles

On Wednesday (July 24), Quebec announced regulations to block the sale of cannabis edibles that would directly appeal to minors, such as desserts and chocolate edible products. These products are set to become legal in Canada later this year.

The province is also looking to prevent the sale of cannabis topical items.

The Cannabis Council of Canada, a group representing the interests of licensed producers, called the decision by Quebec a win for the black market.

“(The) decision by the Quebec government to issue draft regulation with respect to edible cannabis products and cannabis extracts is extremely disappointing. If implemented, the efforts of the legal cannabis industry to replace the illicit market and keep cannabis out of the hands of minors will be severely hindered,” Megan McCrae, board chair of the council and vice president of marketing at Aphria (NYSE:APHA,TSX:APHA), said in a statement.

Market updates

On Tuesday (July 23), a new marijuana-centric ETF that will be actively managed by Tim Seymour, CIO of Seymour Asset Management and co-host CNBC’s Fast Money, reached the public market.

The Amplify Seymour Cannabis ETF (ARCA:CNBS) gives investors exposure to 25 marijuana holdings, with the top five holdings representing some of the biggest firms in the space.

Aurora Cannabis (NYSE:ACB,TSX:ACB), GW Pharmaceuticals (NASDAQ:GWPH) and Canopy Growth (NYSE:CGC,TSX:WEED) are the top three holdings by weightage in the fund. The total net asset value for the Amplify Seymour Cannabis ETF is US$2.47 million.

“The global legal cannabis industry is still very much in its infancy and presents an attractive growth opportunity for investors looking to capitalize on this emerging frontier,” said Seymour.

As interest in edibles and the ingestible market in Canada rises, the Tinley Beverage Company (CSE:TNY,OTCQX:TNYBF) confirmed it is inching closer to a deal with a Canadian company in order to bring its cannabis-infused line of drinks north of the border.

“Health Canada hasn’t finalized the manufacturing licenses yet. As soon as those types of licenses are awarded to our intended partner, we’re ready to go,” Jeff Maser told Yahoo Finance Canada. The executive did not disclose the potential partner for his company.

Cannabis-infused drinks will become legal in Canada as part of the second phase of legalization taking effect on October 17. However, Health Canada, the regulatory agency tasked with overseeing the cannabis industry, confirmed the launch of these products will take time and has said that actual sales will start in December.

Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) was issued a warning on Monday (July 22) from the US Food and Drug Administration (FDA) for unsubstantiated claims regarding some of its hemp-derived products.

The FDA highlighted four CBD-based products sold online by the multi-state operator (MSO) that are making improper medical claims. The federal agency also said that several elements of the MSO’s website need to be updated.

“We can affirm that nothing in the letter raises any issues concerning the quality and consistency of any Curaleaf product or calls into question the high safety standards of the company’s cultivation and manufacturing processes,” the firm said. It plans to respond to the agency about its requests.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less